Mesh.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Mesh.i » - entrée « Drug Eruptions »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Drug Dosage Calculations < Drug Eruptions < Drug Evaluation  Facettes :

List of bibliographic references indexed by Drug Eruptions

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
001089 (2018) Chia-Hua Lin [Taïwan] ; Hsiang-Cheng Chen [Taïwan] ; Hong-Wei Gao [Taïwan] ; Bai-Yao Wu [Taïwan]Wolf's post-herpetic isotopic response to tocilizumab for rheumatoid arthritis.
001205 (2018) Jean-Hugues Salmon ; Jeanne-Marie Perotin ; Jacques Morel [France] ; Moustapha Dramé ; Alain Cantagrel [France] ; Liana Euller Ziegler ; Philippe Ravaud [France] ; Jean Sibilia ; Isabelle Pane [France] ; Xavier Mariette ; Jacques-Eric Gottenberg [France]Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data.
001385 (2018) Y. Mansour [France] ; A. Lambert [France] ; M. Tebacher-Alt [France] ; J L Pasquali [France] ; D. Lipsker [France]Eruptive nevi under tocilizumab: first case report and data analysis.
001591 (2017) Tatsuhiko Mori [Japon] ; Toshiyuki Yamamoto [Japon]Tocilizumab-induced pustular drug eruption.
001A94 (2016) Kaoru Hamada [Japon] ; Yu Sawada [Japon] ; Takashi Yamaguchi [Japon] ; Shun Ohmori [Japon] ; Daisuke Omoto [Japon] ; Sanehito Haruyama [Japon] ; Manabu Yoshioka [Japon] ; Daisuke Nishio [Japon] ; Motonobu Nakamura [Japon]Photosensitivity due to tocilizumab presenting with erythema multiforme-like lesions.
001B58 (2016) Coline Faivre [France] ; Axel Patrice Villani [France] ; François Aubin [France] ; Dan Lipsker [France] ; Martine Bottaro [France] ; Jean-David Cohen [France] ; François Durupt [France] ; Géraldine Jeudy [France] ; Emilie Sbidian [France] ; Eric Toussirot [France] ; Valérie Badot [Belgique] ; Sébastien Barbarot [France] ; Sébastien Debarbieux [France] ; Emmanuel Delaporte [France] ; Guetty Goegebeur [France] ; Jacques Morel [France] ; Aude Nassif [France] ; Gérard Duru [France] ; Denis Jullien [France]Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases.
001E48 (2015) Marie Fechtenbaum [France] ; Christopher Banse [France] ; Pauline Boyard-Lasselin [France] ; Vincent Goëb [France]Toxidermia under treatment with tocilizumab for rheumatoid arthritis.
001E52 (2015) Cheng-Pin Wu [République populaire de Chine] ; Chia-Wei Hsieh [République populaire de Chine] ; Der-Yuan Chen [République populaire de Chine] ; Bor-Jen Lee [République populaire de Chine] ; Chii-Shuenn Yang [République populaire de Chine]Tocilizumab-associated cutaneous reactive endotheliomatosis in a patient with rheumatoid arthritis.
001F42 (2015) Luca Cantarini [Oman] ; Giuseppe Lopalco ; Antonio Vitale ; Laura Coladonato ; Donato Rigante ; Orso Maria Lucherini ; Giovanni Lapadula ; Florenzo IannoneParadoxical mucocutaneous flare in a case of Behçet's disease treated with tocilizumab.
002271 (2014) L. Sparsa [France] ; N. Afif [France] ; S. Bularca [France] ; A. Fricker [France] ; S. Thiebault [France] ; E. Dahan [France] ; D. Wendling [France] ; J. Sibilia ; M. Ardizzone [France][Paradoxical cutaneous reactions associated with tocilizumab therapy].
002296 (2014) Natalia Palmou-Fontana [Espagne] ; Juan Antonio Sánchez Gavi O ; Dennis Mcgonagle ; Eva García-Martinez ; Luis I Iguez De Onzo O MartínTocilizumab-induced psoriasiform rash in rheumatoid arthritis.
002509 (2014) Jorge Enrique Machado-Alba [Colombie] ; Andrés Felipe Ruiz [Colombie] ; Manuel Enrique Machado-Duque [Colombie]Adverse drug reactions associated with the use of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.
002615 (2014) P. Jayasekera [Royaume-Uni] ; R. Parslew [Royaume-Uni] ; A. Al-Sharqi [Royaume-Uni]A case of tumour necrosis factor‐α inhibitor‐ and rituximab‐induced plantar pustular psoriasis that completely resolved with tocilizumab
003D92 (2010) R. Yoshiki [Japon] ; M. Nakamura [Japon] ; Y. Tokura [Japon]Drug eruption induced by IL‐6 receptor inhibitor tocilizumab
004293 (????) Motonobu Nakamura ; Yoshiki TokuraTocilizumab-induced erythroderma.
004408 (????) Benoit Ben Said [France] ; Mathieu Gerfaud-Valentin [France] ; Pascal Seve [France]Fatal DRESS syndrome under tocilizumab treatment for seronegative polyarthritis.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Drug Eruptions" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Drug Eruptions" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Drug Eruptions
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021